Clinical Trials Browser

Recruiting × Lymphoma, Large B-Cell, Diffuse × pembrolizumab × Clear all

NCT06863402 2025-12-23

Nemtabrutinib and Pembrolizumab for the Treatment of Richter Transformation, Diffuse Large B-cell Lymphoma Subtype

Phase 2 Recruiting

LymphoidOther hematologic neoplasm

Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, Large B-Cell, Diffuse

NCT04920617 2023-04-07

VITALIZE

Phase 2 Recruiting

Lymphoma, Large B-Cell, Diffuse